172 related articles for article (PubMed ID: 31926078)
1. Machine learning as new promising technique for selection of significant features in obese women with type 2 diabetes.
Lotfi H; Pirmoradi S; Mahmoudi R; Teshnehlab M; Sheervalilou R; Fekri Aval S; Zarghami N
Horm Mol Biol Clin Investig; 2020 Jan; 41(1):. PubMed ID: 31926078
[TBL] [Abstract][Full Text] [Related]
2. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
[TBL] [Abstract][Full Text] [Related]
3. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.
Li L; Yang G; Li Q; Tang Y; Yang M; Yang H; Li K
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):544-8. PubMed ID: 17177135
[TBL] [Abstract][Full Text] [Related]
4. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: a prospective study.
Díaz-Soto G; de Luis DA; Conde-Vicente R; Izaola-Jauregui O; Ramos C; Romero E
Diabetes Res Clin Pract; 2014 Apr; 104(1):92-6. PubMed ID: 24530118
[TBL] [Abstract][Full Text] [Related]
6. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
Zhang XJ; Wang Z; Li HH; Yu L; Gao S
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism rs9939609 of Fat Mass and Obesity-associated Gene Correlation with Leptin Level of Obese Women Suffered from Type 2 Diabetes.
Moghanloo MN; Mohammadzadeh NA; Lotfi H; Mahmoudi R; Abbasi M; Alipour FG; Shool F; Porfaraj S; Zarghami N
Curr Diabetes Rev; 2018; 14(6):559-564. PubMed ID: 28914195
[TBL] [Abstract][Full Text] [Related]
8. Compare the effects of different visfatin concentration on cardiovascular risk factors, adiponectin and insulin resistance in patients with T2DM.
Mohammadi S; Hosseinzadeh-Attar MJ; Hosseinnezhad A; Hosseini SH; Eshraghian MR; Nezhad MK; Rahmani M; Karimi M
Diabetes Metab Syndr; 2011; 5(2):71-5. PubMed ID: 22813406
[TBL] [Abstract][Full Text] [Related]
9. Apelin, vaspin, visfatin and adiponectin in large for gestational age infants with insulin resistance.
Cekmez F; Canpolat FE; Pirgon O; Çetinkaya M; Aydinoz S; Suleymanoglu S; Ipcioglu OM; Sarici SU
Cytokine; 2011 Nov; 56(2):387-91. PubMed ID: 21742512
[TBL] [Abstract][Full Text] [Related]
10. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance.
Silha JV; Krsek M; Skrha JV; Sucharda P; Nyomba BL; Murphy LJ
Eur J Endocrinol; 2003 Oct; 149(4):331-5. PubMed ID: 14514348
[TBL] [Abstract][Full Text] [Related]
11. Serum visfatin, resistin and IL-18 in A group of Egyptian obese diabetic and non diabetic individuals.
Mabrouk R; Ghareeb H; Shehab A; Omar K; El-Kabarity RH; Soliman DA; Mohamed NA
Egypt J Immunol; 2013; 20(1):1-11. PubMed ID: 23888552
[TBL] [Abstract][Full Text] [Related]
12. Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study.
Mir MM; Mir R; Alghamdi MAA; Wani JI; Sabah ZU; Jeelani M; Marakala V; Sohail SK; O'haj M; Alharthi MH; Alamri MMS
J Pers Med; 2022 May; 12(5):. PubMed ID: 35629157
[TBL] [Abstract][Full Text] [Related]
13. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
[TBL] [Abstract][Full Text] [Related]
14. [Role of visfatin in the pathogenesis of gestational diabetes mellitus and its relationship with insulin resistance].
Huo Y; Liu S; Feng J; Li H; Fan Y; Jin Y; Li L
Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):584-7. PubMed ID: 25354858
[TBL] [Abstract][Full Text] [Related]
15. Association of the + 45T>G adiponectin gene polymorphism with insulin resistance in non-diabetic Saudi women.
Mackawy AM
Gene; 2013 Nov; 530(1):158-63. PubMed ID: 23958652
[TBL] [Abstract][Full Text] [Related]
16. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.
Dogru T; Sonmez A; Tasci I; Bozoglu E; Yilmaz MI; Genc H; Erdem G; Gok M; Bingol N; Kilic S; Ozgurtas T; Bingol S
Diabetes Res Clin Pract; 2007 Apr; 76(1):24-9. PubMed ID: 16956691
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of visfatin, resistin and adiponectin in patients with psoriatic arthritis and associations with disease severity.
Dikbas O; Tosun M; Bes C; Tonuk SB; Aksehirli OY; Soy M
Int J Rheum Dis; 2016 Jul; 19(7):672-7. PubMed ID: 25196858
[TBL] [Abstract][Full Text] [Related]
18. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus.
Kadoglou NP; Tsanikidis H; Kapelouzou A; Vrabas I; Vitta I; Karayannacos PE; Liapis CD; Sailer N
Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243
[TBL] [Abstract][Full Text] [Related]
19. RELATIONSHIP OF SERUM RESISTIN WITH INSULIN RESISTANCE AND OBESITY.
Zaidi SI; Shirwany TA
J Ayub Med Coll Abbottabad; 2015; 27(3):552-5. PubMed ID: 26721005
[TBL] [Abstract][Full Text] [Related]
20. Visfatin Serum Levels in Obese Type 2 Diabetic Patients: Relation to Proinflammatory Cytokines and Insulin Resistance.
Hetta HF; Ez-Eldeen ME; Mohamed GA; Gaber MA; ElBadre HM; Ahmed EA; Abdellatief RB; Abd-ElBaky RM; Elkady A; Nafee AM; Zahran AM; Ahmad M
Egypt J Immunol; 2018 Jun; 25(2):141-151. PubMed ID: 30600957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
